Home   HELP  /   AYUDA  /   求助 : help-desk@bctrials.org  /   (888) 282-7099 Click to print page  Print

Browse Trials


In response to COVID-19, some breast cancer trials have temporarily stopped enrolling new patients. Use the contact information in our trial listings to call or email the research site for information about a trial's status.

Visit COVID-19 & Cancer Clinical Trials on Metastatic Trial Talk for regularly updated information about clinical trials during the coronavirus pandemic.


Currently viewing trials
(Last updated: October 14, 2021)

Zip Code:
 

Narrow my choices:

Radius (miles): All U.S.

20 All U.S.
Early stage    Advanced 
Treatment    Non-treatment 
Phase    I     II     III 
Display Only New Trials 
 
Close
Treatment

BRCA1/2 (inherited)

Chemotherapy

Hormone Therapy

Radiation Oncology

Surgery

Surgery: Reconstruction

Targeted Therapy: All

Targeted Therapy: Anti-HER2 Therapy

Targeted Therapy: CDK Inhibitors

Targeted Therapy: PARP Inhibitors

Targeted Therapy: Tumor Mutations

Targeted Therapy: Other Targeted Therapy

Vaccines and Immunotherapy

Other Treatment

Non-Treatment

Activities

Complementary and Alternative Medicine

Decision Support

Diagnosing Breast Cancer

Genetics/Family History

Having Children

Lymphedema

Managing Side Effects

No Travel Required

Predicting Response to Treatment

Preventing Breast Cancer

Preventing Recurrence

Screening

Support/Education

Surveys/Interviews/Registries

Close

AKT

ALK

AR

BARD1

BRCA1/2 (tumor)

BRIP1

CD205

CD70

CHEK2 or CHEK1

ESR1

FGFR

HER2/ERBB2

HLA

MET or C-Met

NTRK

PALB2

PIK3CA or PI3K

PTEN

RAD51

RAF (including BRAF)

RAS (KRAS or NRAS)

RB

ROS1

TP53

1

NEAREST SITE: 348 miles
USC Norris Comprehensive Cancer Center
Los Angeles,CA

VISITS: 1 visit

PHASE: NA

NCT ID: NCT01755208

Using Light-Scattering Spectroscopy in Women with Stage II-III Breast Cancer (or without Breast Cancer) Having a Mammogram at University of Southern California

Light-Scattering Spectroscopy for the Detection of Stage II-III Breast Cancer: A Pilot Study Scientific Title

Purpose
To study if light-scattering spectroscopy can tell apart women with no breast cancer from women with stage II or stage III breast cancer.
Who is this for?
Women with stage II or stage III breast cancer, or women without breast cancer, scheduled to have a mammogram at the University of Southern California.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Light-scattering spectroscopy in addition to standard of care</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Light-scattering spectroscopy (LSS) is an imaging technique that does not require the removal of tissue samples and can provide quick results.</li> <li class="seamTextUnorderedListItem">LSS may be able to identify cell abnormalities more effectively than a biopsy.</li></ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT01755208' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='http://www.ncbi.nlm.nih.gov/pubmed/17280544' target='_blank'>Journal Article: Optical Diagnostic Technology Based on Light Scattering Spectroscopy for Early Cancer Detection</a> </li></ul>
See more
2

NEAREST SITE: 2386 miles
Duke University Medical Center
Durham,NC

VISITS: 1 visit

PHASE: NA

NCT ID: NCT00734838

Optical Spectroscopy for Diagnosing Breast Cancer

Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy Scientific Title

Purpose
To study whether optical spectroscopy is an effective tool for identifying breast cancer cells.
Who is this for?
Women planning to have a needle biopsy of a breast mass.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> Participants will be assigned to 1 of 2 diagnostic techniques based on their cancer status: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Scheduled for Surgery</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Optical spectroscopy for 5-10 minutes during the scheduled procedure </li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Scheduled for Biopsy</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Optical spectroscopy will be used on the tissue removed during the biopsy, and will require no additional time</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Optical spectroscopy uses special instruments and a low power light to identify cancerous cells in body tissue. </li> <li class="seamTextUnorderedListItem">It currently is used to detect a number of different types of cancer. </li> <li class="seamTextUnorderedListItem">To be eligible, individuals must be scheduled to have a mastectomy or lumpectomy, or be scheduled to have a biopsy because their mammogram suggests they have a high likelihood of having breast cancer.</li> </ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT00734838' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='http://www.uhnresearch.ca/tdc/documents/DO-7-1008MT.pdf' target='_blank'>UHN: Optical Breast Spectroscopy Overview</a> </li><li class='seamTextUnorderedListItem'><a href='http://www.pnas.org/content/98/8/4420.full.pdf' target='_blank'>PNAS: Optical Breast Spectroscopy</a> </li></ul>
See more